At 2% concentration, this serum delivers a meaningful clinical dose with every application
Expectations from phase 2 were pointing towards 14-15% weight loss vs 11.2%, but this is why we perform clinical trials
Here's what nobody's telling you: the basics wo
Produced in a cGMP-Compliant Facility: Manufactured in a facility that follows current Good Manufacturing Practices (cGMP), ensuring a consistent and reliable product
The maintenance of thioredoxin in a reduced form by TXNRDs is important for regulating cell growth and survival
Next steps in clinical translation First-in-human safety trials (phase I) are essential: to assess dose tolerability, pharmacokinetics, biodistribution, peptide half-life, clearance, immunogenicity